Alex Baxter

4.2k citations
15 papers · 3.3k · 2 hit papers · h-index 15

Impact in

  • Nephrology top 0.5%
    • Chronic Kidney Disease and Diabetes
    • Dialysis and Renal Disease Management
    • Renal Diseases and Glomerulopathies
    • Parathyroid Disorders and Treatments
  • Surgery top 1%
    • Lipoproteins and Cardiovascular Health
    • Cholesterol and Lipid Metabolism

Papers in

    • Chronic Kidney Disease and Diabetes 6
    • Dialysis and Renal Disease Management 1
    • Lipoproteins and Cardiovascular Health 10

Alex Baxter

15 papers receiving 3.1k citations

Alex Baxter's Hit Papers

HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment 2013 · 567 citations
5670+5+10Years since publication5001k1.5k

Peers

Alex Baxter
Comparison fields: 5 of 75
  • Nephrology 1.2k
  • Surgery 1.7k
  • Transplantation 56
  • Cardiology and Cardiovascular Medicine 346
  • Endocrinology, Diabetes and Metabolism 195
Replace Tanaji Dasgupta with:
Tanaji Dasgupta United Kingdom
William Majoni Australia
Udom Krairittichai Thailand
Marion Mafham United Kingdom
Dimitrios Tsakiris United Kingdom
EVA K. JOHNSSON Sweden
Mattis Gottlow Sweden
Sandor Sonkodi Hungary
Wilbert M.T. Janssen Netherlands
Marián Goicoechea Spain
Alex Baxter relative to Tanaji Dasgupta United Kingdom Tanaji Dasgupta's profile →
Citations per field
00.5×1.5×1.8×
Tanaji Dasgupta · 1×
Citations per year

Countries citing papers authored by Alex Baxter

Since Specialization
Citations

This map shows the geographic impact of Alex Baxter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Baxter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Baxter more than expected).

Fields of papers citing papers by Alex Baxter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex Baxter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Baxter. The network helps show where Alex Baxter may publish in the future.

Co-authors

The 19 scholars most cited alongside Alex Baxter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alex Baxter Line = papers co-authored together Alex Baxter links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Hit paper breakdown →
20111952
2
HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment
Hit paper breakdown →
2013567
3 2005159
4 2014151
5 200682
6 202379
7 201672
8 202366
9 202150
10 201737
11 201731
12 201526
13 201922
14 201321
15 201917

About Alex Baxter

Alex Baxter is a scholar working on Nephrology, Surgery, Transplantation, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine, having authored 15 papers that have together received 3.3k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (10 papers), Chronic Kidney Disease and Diabetes (6 papers), Smoking Behavior and Cessation (1 paper), Antiplatelet Therapy and Cardiovascular Diseases (1 paper), Renal Transplantation Outcomes and Treatments (1 paper), Diabetes Treatment and Management (1 paper) and Dialysis and Renal Disease Management (1 paper). The work is most often cited by research in Nephrology (1.2k citations), Surgery (1.7k citations), Transplantation (56 citations), Cardiology and Cardiovascular Medicine (346 citations) and Endocrinology, Diabetes and Metabolism (195 citations). Alex Baxter has collaborated with scholars based in United Kingdom, Australia and New Zealand. Frequent co-authors include David Collins. Wheeler, Craig Leaper, Paul Altmann, Martin Landray, Charles Tomson, Jane Armitage, Graham L. Warwick, Rory Collins, Hugh Cairns and Colin Baigent. Their work appears in journals such as American Journal of Kidney Diseases, European Heart Journal, The Lancet Diabetes & Endocrinology, Kidney International and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact